Skip to main content
eScholarship
Open Access Publications from the University of California

A screen of Crohn's disease-associated microbial metabolites identifies ascorbate as a novel metabolic inhibitor of activated human T cells.

  • Author(s): Chang, Yu-Ling
  • Rossetti, Maura
  • Vlamakis, Hera
  • Casero, David
  • Sunga, Gemalene
  • Harre, Nicholas
  • Miller, Shelley
  • Humphries, Romney
  • Stappenbeck, Thaddeus
  • Simpson, Kenneth W
  • Sartor, R Balfour
  • Wu, Gary
  • Lewis, James
  • Bushman, Frederic
  • McGovern, Dermot PB
  • Salzman, Nita
  • Borneman, James
  • Xavier, Ramnik
  • Huttenhower, Curtis
  • Braun, Jonathan
  • et al.
Abstract

Microbial metabolites are an emerging class of mediators influencing CD4+ T-cell function. To advance the understanding of direct causal microbial factors contributing to Crohn's disease, we screened 139 predicted Crohn's disease-associated microbial metabolites for their bioactivity on human CD4+ T-cell functions induced by disease-associated T helper 17 (Th17) polarizing conditions. We observed 15 metabolites with CD4+ T-cell bioactivity, 3 previously reported, and 12 unprecedented. A deeper investigation of the microbe-derived metabolite, ascorbate, revealed its selective inhibition on activated human CD4+ effector T cells, including IL-17A-, IL-4-, and IFNγ-producing cells. Mechanistic assessment suggested the apoptosis of activated human CD4+ T cells associated with selective inhibition of energy metabolism. These findings suggest a substantial rate of relevant T-cell bioactivity among Crohn's disease-associated microbial metabolites, and evidence for novel modes of bioactivity, including targeting of T-cell energy metabolism.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Main Content
Current View